Abstract 9838: Safety and Feasibility of Staged or Concomitant Transcatheter Edge-to-Edge Mitral Valve Repair After Transcatheter Aortic Valve Replacement

IntroductionThe data on safety and feasibility of performing concomitant or staged Transcatheter Edge-to-Edge Repair (TEER) of the mitral valve with Transcatheter Aortic Valve Replacement (TAVR) remains limited. HypothesisMethodsThe Nationwide Readmission Database (NRD) was utilized to identify TEER...

Full description

Saved in:
Bibliographic Details
Published in:Circulation (New York, N.Y.) N.Y.), 2022-11, Vol.146 (Suppl_1), p.A9838-A9838
Main Authors: Zahid, Salman, Hashem, Anas, Khan, Muhammad Z, balla, sudarshan
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:IntroductionThe data on safety and feasibility of performing concomitant or staged Transcatheter Edge-to-Edge Repair (TEER) of the mitral valve with Transcatheter Aortic Valve Replacement (TAVR) remains limited. HypothesisMethodsThe Nationwide Readmission Database (NRD) was utilized to identify TEER and TAVR procedures from 2015, to 2019, using ICD-10-CM administrative claim codes. ResultsA total of 28,180 weighted cases of TEER were included in the analysis. Of the included cases 27,562 underwent TEER as a separate procedure and were compared with TEER cases performed concomitantly with TAVR (n=174) or performed as a staged procedure (n=453). In terms of crude outcomes, in-hospital mortality (4.4% vs 2.1%, p
ISSN:0009-7322
1524-4539
DOI:10.1161/circ.146.suppl_1.9838